Navigation Links
Convection Cooled 350-Watt Open Frame Power Supply Meets Medical and Industrial Safety Standards

CHICAGO, July 24 /PRNewswire/ -- International Components Corporation (ICC), an established global leader in designing and manufacturing portable rechargeable systems, today launched a new series of high-efficiency AC-DC open-frame, single-output power supplies. The new 350-watt series, designed for both industrial (FXA350) and medical applications (MSMP250), delivers an industry-leading converter efficiency of up to 88%. The power supply is maximized for performance and features 5V standby output current and adjustable fan output current. The 350-watt series is the latest addition to the company's rapidly expanding portfolio of high-efficiency, high-reliability power supplies.

Maintaining the company's commitment to premium design, both the FXA350 and MSMP250 series features 350 watts of continuous output power with just 5 CFM of airflow. This high-reliability series offers active power factor correction of .98 to minimize input harmonic current distortion and ensure compliance with the international EN61000-3-2 standard. The 350-watt series also delivers a long hold-up time for reliable operation at more than 22ms at any input voltage. No minimum load is required for the unit to start up and maintain stated specifications.

The power supplies are comprehensively protected against over-voltage, over-temperature, and short circuit conditions and demonstrated mean time between failure exceeds 200,000 hours. The units operate at full power from 0 to + 50 degrees C and up to + 70 degrees C with derating. Both the FXA350 and MSMP250 series feature a universal input range of 85 to 264 VAC enabling use in any part of the world.

The FXA350 and the MSMP250 series are competitively priced, starting at $119.00 in OEM quantities of 1,000 and models are available to ship today. The 350-watt series is conveniently available in five single-output voltages ranging from 12-48 VDC. ICC can also design a 100-percent custom solution to meet specific OEM requirements. Full warranty policy and datasheets with complete technical specifications for the 350-watt series can be found 24/7 at

About International Components Corporation and Elpac Power Systems

Founded in 1967, ICC is an established global developer and manufacturer of innovative power solutions for portable applications. The company continues to lead the industry with expertise in designing and manufacturing rechargeable battery solutions, custom chargers, docking stations, and highly efficient power supplies marketed under the Elpac Power Systems brand name. ICC is committed to providing high-quality, technologically advanced solutions to its partners in the medical, communications, data server and storage, handheld data, and consumer electronics markets.


    Elizabeth Miller
    International Components Corporation

This release was issued through eReleases(TM). For more information, visit

SOURCE International Components Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Convection Cooled 150-Watt Open Frame Power Supply Meets Medical and Industrial Safety Standards
2. Perot Systems Webinar: An Industry Perspective on the HIT Standards Committees Framework for Meaningful Use
3. Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls
4. Perot Systems Webinar: An Industry Perspective on HIT Policy Committees Framework for Meaningful Use
5. Former Senate Majority Leaders Baker, Daschle and Dole Release Bipartisan Framework for Comprehensive Health Reform
6. MedTrust Online Completes Second Round of Financing, Releases Next Generation Search Engine for Oncology Utilizing Dell eHealthcare Architecture Framework
7. AHIP Statement on Cost Containment Framework
8. CSC and AORN Bring Standardized Electronic Health Framework to Perioperative Nursing Care
9. AMICAS Delivers Advanced Integration Framework to Monroe Clinic
10. Congressional Leaders, Public Health Experts Announce New Framework to Promote Womens Health
11. AMB New Generation Data Empowerment Joins Mainframe Migration Alliance
Post Your Comments:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: